Society for Immunotherapy of Cancer (SITC) - Dedicated to improving cancer patient outcomes by advancing the field of tumor immunology and cancer immunotherapy.
Milwaukee, WI
- Tweets 15,728
- Following 6,441
- Followers 20,128
- Likes 8,161
Pinned Tweet
Register for our 41st Annual Meeting and Pre-Conference Programs. #SITC26 provides a multidisciplinary educational & interactive environment focused on improving outcomes for cancer patients. Attend in person or virtually: sitcancer.org/2026/home
1
1
2
937
Society for Immunotherapy of Cancer retweeted
New #JITC article: "PCSK9 drives acquired resistance to anti-PD-1 immunotherapy through cystine metabolic reprogramming in lung cancer" doi.org/10.1136/jitc-2026-01…
5
10
515
Society for Immunotherapy of Cancer retweeted
Looking forward to #SITC26!
Register for our 41st Annual Meeting and Pre-Conference Programs. #SITC26 provides a multidisciplinary educational & interactive environment focused on improving outcomes for cancer patients. Attend in person or virtually: sitcancer.org/2026/home
1
3
2
345
Register for our 41st Annual Meeting and Pre-Conference Programs. #SITC26 provides a multidisciplinary educational & interactive environment focused on improving outcomes for cancer patients. Attend in person or virtually: sitcancer.org/2026/home
1
1
6
799
Join experts in the IO field at Spring Scientific. Held Feb. 24–26 in San Diego, CA or virtual. This program will include in-depth discussions of cutting-edge technologies, and the newest clinical studies. Learn more and register here: sitcancer.org/edu/2027-sprin…
2
5
603
Connect with SITC members who share your scientific interests! Explore SITC’s three active Special Interest Groups (SIGs): ASPIRE, Peri-IO Safety and Microbiome. Discover opportunities to network, collaborate and advance cancer immunotherapy. Learn more: sitcancer.org/get-involved/s…
2
2
4
852
Use the Career Connections Online Job Board to find the right candidates for your open job positions. Through Nov. 30, save 20% on a single, 3- or 5- pack of job posts using code SITC26JOB or SITC26PACK. Learn more here: careerconnections.sitcancer.…
2
436
The SITC Sparkathon 2027 topic is “Next Generation of Cellular Therapies: In vivo, Ex vivo, Engagers and Beyond”. Apply by Nov. 12 and learn more about leadership development, collaborations & scientific exchange. sitcancer.org/sparkathon
2
3
5
618
Society for Immunotherapy of Cancer retweeted
New #JITC article: "Selective expansion of neoantigen-specific peripheral blood lymphocytes through antigen-presenting cell-T cell conjugate isolation" doi.org/10.1136/jitc-2026-01…
8
11
1,089
Society for Immunotherapy of Cancer retweeted
CRI STAR Sidi Chen, PhD (@sidichen) of @YaleMed joins @sitcancer for a webinar on systems immunology and T cell memory, key to durable immunotherapy responses. 🧬
🕛 Tue., Oct. 27 | 12–1:30 p.m. ET
Register: bit.ly/3U6Am1y
#CancerImmunotherapy #TCells
1
2
9
910
Hear directly from pharma leaders at High-Impact Talks from Pharma Leaders during #SITC26! Gain insights into oncology innovation, early research and development, and how emerging companies can align scientific promise with industry priorities. Join us! sitcancer.org/2026/schedule/…
3
2
2
524
Society for Immunotherapy of Cancer retweeted
New #JITC article: "Sensory innervation shapes cancer immunotherapy efficacy and adverse events" doi.org/10.1136/jitc-2026-01…
4
5
505
Society for Immunotherapy of Cancer retweeted
New #JITC article: "CCNE1 overexpression drives a cGAS–STING-dependent interferon response and sensitizes HRD-positive ovarian cancer to immune checkpoint blockade" doi.org/10.1136/jitc-2026-01…
5
11
799
Congratulations! See you in Phoenix!
🎉 We are excited to announce that Bushangqing Liu, a PhD candidate at @DukeU, has been selected as Biointron’s Q4 2026 Travel Grant recipient!
📍 Liu will be attending @sitcancer (SITC 2026) from Nov 4-8. Biointron will be at booth #712!
biointron.com/promotions/tra…
2
5
670
Society for Immunotherapy of Cancer retweeted
New #JITC article: "Affinity-optimized bispecific CAR-T cells targeting HLA-G and CD70 for the treatment of clear cell renal cell carcinoma" doi.org/10.1136/jitc-2026-01…
4
8
589
Society for Immunotherapy of Cancer retweeted
New #JITC article: "AI-derived 3D body composition predicts prognosis of chemoimmunotherapy in small cell lung cancer: a multicenter study" doi.org/10.1136/jitc-2026-01…
2
5
5
723
Explore systems immunology and T cell memory with #SITC! Join us Oct. 27 for the next webinar in the Computational IO Series and hear from experts about computational approaches advancing our understanding of immune responses. Register today! sitcancer.org/edu/webinars/c…
1
4
7
749
Society for Immunotherapy of Cancer retweeted
New #JITC article: "Dietary fat boosts lung tissue-specific antitumor immunity via reprogramming intravascular neutrophils" doi.org/10.1136/jitc-2026-01…
6
20
1,293
Society for Immunotherapy of Cancer retweeted
👉
Abstract submissions for Spring Scientific are open through Dec. 3, 2026. Don’t miss this opportunity to share your research with your colleagues and fellow immuno-oncology professionals. Learn more about the program and register: sitcancer.org/edu/2027-sprin…
1
1
180
Society for Immunotherapy of Cancer retweeted
We’re presenting our trial in progress at #SITC2026 in Phoenix: BND-22 in combination with cemiplimab in patients with cholangiocarcinoma. @ANaingMD @UTMDAnderson @sitcancer
Made with AI
1
3
295
Society for Immunotherapy of Cancer retweeted
We’re pleased to share that a Genelux Trial-in-Progress abstract has been accepted for presentation at #SITC26!
The presentation will highlight the clinical trial design and science supporting the VIRO-25 clinical trial evaluating Olvimulogene Nanivacirepvec (Olvi-Vec), an oncolytic vaccinia virus-based immunotherapy, in combination with chemotherapy and an immune checkpoint inhibitor in non-small cell lung cancer.
Abstract #540: Clinical trial of Olvimulogene Nanivacirepvec (Olvi-Vec), an oncolytic vaccinia virus-based immunotherapy, plus chemotherapy and an immune checkpoint inhibitor in Non-Small Cell Lung Cancer (VIRO-25).
We look forward to seeing you in Phoenix, Nov. 4–8!
Learn more about the @sitcancer's 41st Annual Meeting and register: sitcancer.org/2026/home
3
4
283